Influencing the activity of somatic comorbidities through trauma-centered psychotherapy with EMDR using autoimmune thyroiditis Hashimoto as an example

• Conditions: Hashimotos Thyreroditis; F43.1; Post-traumatic stress disorder

• Registration Number: DRKS00030624
• Lead Sponsor: Praxis für EMDR

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-12-09
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting withdrawn before recruiting started
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

PTSD and comorbidity autoimmune thyroiditis Hashimoto's disease

Exclusion Criteria

Age under 18, age over 65

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
in parallel with trauma-focused treatment with EMDR with integration of traumatic memory and regulation of emotional stress, is the autoimmune activity of Hashimoto's autoimmune thyroiditis comorbidity reduced? The substitution dose (thyroid hormone substitution with medication) serves as the measurement parameter. This parameter is checked before the start of trauma-centered psychotherapy with EMDR, during, at the end of, and three months after the end of therapy using the medication schedule.

Secondary Outcome Measures

Name	Time	Method
correlates autoimmune activity measured by substitution dose at the conclusion of trauma-centered psychotherapy with parameters for traumatic stress measured by the IES-R (Impact of Event Scale-Revised).